CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 160 enrolled
Drug / intervention
ready-to-use root canal sealer: PA1704 +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04757753
NCT04757753N/AActive

Evaluation of the Efficacy Rate of Endodontic Treatment at 2 Years After Root Canal Filling With a Ready-to-use Root Canal Sealer PA1704 Versus BioRoot™ RCS: a Randomized Controlled Trial

Septodont·interventional·Posted Feb 17, 2021·Updated Jun 8, 2026

In Brief

A clinical study evaluating ready-to-use root canal sealer: PA1704 and root canal sealer: BioRoot™ RCS for Root Canal Obturation. Active but no longer recruiting, targeting 160 participants across 5 sites in 2 countries.

Detailed Summary

The study design is a multicentric randomized controlled non-inferiority trial. 160 subjects (teeth) requiring a primary or a secondary root canal treatment will be enrolled in 2 groups (80 in each group). The aim of the study is to assess the efficacy rate and the safety 2 years after root canal obturation undertaken using a ready-to-use calcium silicate sealer (PA1704) compared to the control calcium silicate sealer BioRoot™ RCS. Procedures of root canal treatment will be conventional and standardized for all investigational centers. The canals will be cleaned, shaped and then obturated using a calcium silicate sealer (the ready to use sealer PA1704 or BioRoot™ RCS) with a single cone technique or cold lateral condensation of gutta-percha. Follow-up assessments will be conducted at 6, 12 and 24 months in both groups. The performance and safety of the sealer PA1704 will also be evaluated at 3.5 and 5 years after surgery. Retroalveolar radiographs will be taken at each study visit. The preoperative, postoperative and follow-up clinical and radiographic data will be analyzed.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesBelgium, France
CollaboratorsSlb Pharma

Timeline

N/AActive
2021202220232024202520262027
First PostedFeb 17, 2021
Enrollment StartNov 6, 2020
Primary CompletionAug 29, 2023
Study CompletionDec 1, 2026
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 5.4 years ago

Interventions

ready-to-use root canal sealer: PA1704device

The participant will be treated with the ready-to-use root canal sealer (PA1704) in combination with gutta percha.

root canal sealer: BioRoot™ RCSdevice

The participant will be treated with BioRoot™ RCS sealer in combination with gutta percha.